KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to -$75.8 million.

  • Globus Medical's Cash from Investing Activities fell 40672.81% to -$75.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$347.7 million, marking a year-over-year decrease of 23980.96%. This contributed to the annual value of -$176.1 million for FY2024, which is 15810.88% down from last year.
  • Per Globus Medical's latest filing, its Cash from Investing Activities stood at -$75.8 million for Q3 2025, which was down 40672.81% from -$299.1 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Cash from Investing Activities registered a high of $320.6 million during Q4 2023, and its lowest value of -$299.1 million during Q2 2025.
  • In the last 5 years, Globus Medical's Cash from Investing Activities had a median value of -$15.0 million in 2024 and averaged -$31.7 million.
  • Per our database at Business Quant, Globus Medical's Cash from Investing Activities plummeted by 472692.9% in 2021 and then surged by 1906923.08% in 2022.
  • Over the past 5 years, Globus Medical's Cash from Investing Activities (Quarter) stood at -$243.8 million in 2021, then skyrocketed by 75.19% to -$60.5 million in 2022, then soared by 630.08% to $320.6 million in 2023, then plummeted by 132.48% to -$104.1 million in 2024, then increased by 27.16% to -$75.8 million in 2025.
  • Its Cash from Investing Activities stands at -$75.8 million for Q3 2025, versus -$299.1 million for Q2 2025 and $131.4 million for Q1 2025.